This is the latest episode of the free DDW podcast, “How to improve process while maintaining quality”. It covers two narrated articles written for Volume 22, Issue 4 – Fall 2021 of DDW. They are called “How can the bioprocess industry respond to cost and maintain quality?” and “RNA: a coming-of-age technology for viral vaccines”.
In the first article, Grant Cameron, Director at Clydeworth Consulting, examines the benefits of process intensification and highlights the steps which will improve process productivity, reduce environmental impact and decrease the cost of therapy manufacture while maintaining product quality.
In the second article, Dr Andy Lane, Commercial Director at The Native Antigen Company, discusses the development of a new generation of vaccine platforms that can be rapidly adapted to novel threats on-demand and at low cost.